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Key findings
Data from the National 
Health and Nutrition 
Exam ination Survey  
1999-2004
• Los Angeles County 
(LAC) had more Mexican 
American or “Other” and fewer 
non-Hispanic white persons
as compared with the U.S. 
population.
• Seropositivity, measured as 
the presence o f antibody, to 
hepatitis A virus (HAV) was 
greater among the total and 
Mexican-American populations 
in LAC as compared with the 
United States.
• There were no significant 
differences in seropositivity 
to measles, mumps, rubella, 
varicella, herpes simplex virus 
type 1 (HSV-1) and type 2 
(HSV-2) between LAC and the 
U.S. total populations.
• Differences in seropositivity 
to cytomegalovirus (CMV) 
and to Toxoplasma gondii (T. 
gondii) between LAC and the 
U.S. total populations were
no longer significant when 
comparing the two Mexican- 
American populations.
* SERVIR
Antibody prevalence estimates, markers o f infection with T. gondii, HAV, 
CMV, HSV-1 or HSV-2, or vaccination to measles, mumps, rubella, or 
varicella have been available for the United States but not at the local level 
( 1-8) . Los Angeles County (LAC) was the only county selected each year 
into the NHANES sample. Six years o f data (1999-2004) were combined 
to provide sufficient sample size to create the first estimates o f antibody 
prevalence to these nine infectious diseases based on direct laboratory 
measures for LAC. These estimates o f disease burden or immunization 
success are compared between LAC and the United States.
Keywords: Seroprevalence • National Health and Nutrition Examination 
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How does LAC compare with the total United States with 
respect to race and ethnicity?
LAC had significantly more persons o f Mexican American (34.7%) or “Other” 
(29.2%) race and ethnicity then the total U.S. population (10.2% and 12.1%,









W h ite *
United S tates  
LA C
2 9  2  i_____ ____
10.2 :
3 4 .7  i----------
8 0 100
P ercent
H  C onfidence interval.
* p-va lue fo r d ifferences between the  United S ta tes and the  LAC tota l popula tions is < 0.05. 
NOTE: LAC is Los Ange les County.
SOU RCE: C D C /N CHS, National Health and Nutrition Exam ination Survey, 1999-2004.
s U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention N ational C en ter for H ealth  Statistics
NCHS Data Brief ■ No. 90 ■ April 2012
respectively) (Figure 1) . LAC also had fewer persons o f non-Hispanic white (27.2%) race 
and ethnicity as compared with the race and ethnicity distribution in the total U.S. population 
(64.6%). Differences in the race and ethnicity demographic distribution observed between the 
United States and LAC are supported by census data.
How does LAC compare with the total United States with respect to 
seropositivity to vaccine preventable diseases such as measles, mumps, 
rubella, and varicella?
Seropositivity to all four vaccine preventable diseases, measles, mumps, rubella, and varicella 
was above 90% for both the U.S. and LAC populations (Figure 2) . No significant differences 
between the United States and LAC were found in seropositivity for these four diseases in both 
the total population and the Mexican-American subgroup.
Figure 2. Seropositivity  to m eas les , m um ps, rubella, and varice lla  in LA C  and the United S ta tes  total populations and  
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How does LAC compare with the total United States with respect 
to seropositivity to the enteric diseases hepatitis A virus (HAV) and 
Toxoplasma gondii (T. gondii)?
Seropositivity to HAV, due to either natural infection or vaccination, was greater in LAC (64.8%) 
as compared with the United States (35.9%) and this difference remained when we looked at the 
Mexican-American subgroups alone (76.6% for the United States and 71.3% for LAC) (Figure 
3) . Seropositivity to T. gondii, due to natural infection, was greater in LAC (16.0%) as compared 
with the United States (11.0%). However, there was no significant difference in seroprevalence to 
T. gondii between the U.S. Mexican-American population compared with the Mexican-American 
population in LAC.
Figure 3. Seropositivity to H A V  (ages  6  years  and over) and T  gondii (ages  6 - 4 9  yea rs ) in LA C  and the United S tates  
total populations and am ong the M exican -A m erican  populations, 1 9 9 9 -2 0 0 4
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How does LAC compare with the total United States with respect to 
seropositivity to herpes viral infections such as cytomegalovirus (CMV), 
herpes simplex virus type 1 (HSV-1), and herpes simplex virus type 2 (HSV- 
2)?
Seropositivity to CMV, due to natural infection, was greater in LAC (69.7%) as compared 
with the United States (50.9%) (Figure 4) . However, there was no significant difference in 
seroprevalence to CMV between the Mexican-American population in the United States 
compared with the Mexican American-population in LAC (75.9% and 79.7%, respectively). No 
significant differences between the United States and LAC were found in seropositivity to HSV-1 
or HSV-2.
Figure 4. Seropositivity to C M V  (ages  6 - 4 9  years ) and HSV-1 and H S V -2  (ages  1 4 -4 9  yea rs ) in LA C  and the  
United S ta tes  total populations and  am ong the M exican -A m erican  populations, 1 9 9 9 -2 0 0 4
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Summary
This is the first time seroprevalence of antibody to these nine infectious diseases have been 
available for LAC. Differences in the race and ethnicity distribution of the United States and LAC 
were observed. Because disease prevalence varies by race and ethnicity, in some instances these 
demographic differences affected the population differences seen between the United States and 
LAC in the seroprevalence o f the infectious diseases reported in this study.
Seroprevalence for HAV was higher in LAC as compared with the United States among the 
total population and among the Mexican-American population. California is 1 o f 11 states in 
which routine vaccination o f children was recommended in 1999 by the Advisory Committee on 
Immunization Practices (ACIP) because mean incidence rates in these states were at least twice 
the national mean from 1987-1997 (9) .
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Seroprevalence to CMV and T. gondii have been shown to be higher among Mexican-American 
persons then other race and ethnicity groups ( 1,3) . The higher seropositivity for CMV and T. 
gondii among persons from LAC is due to the higher proportion o f Mexican-American persons in 
the LAC population. No differences in seropositivity were observed when comparing Mexican- 
American persons in the United States and LAC for these two outcomes.
No significant differences in seroprevalence between the United States and LAC were seen 
for measles, mumps, rubella, varicella, HSV-1, and HSV-2. Estimates o f seropositivity from 
immunization or disease for LAC may assist in policy development, program planning, and 
measuring health disparities.
Definitions
Race and ethnicity: Race and ethnicity was based on self-report and categorized as non-Hispanic 
white, non-Hispanic black, and Mexican American. Persons not fitting into these categories were 
classified as “Other” and included in the total population estimates ( 10) .
Measles positivity: Presence o f antibody to measles in blood from either infection or 
immunization (5) ; measured on those persons ages 6-49 years.
Mumps positivity: Presence o f antibody to mumps in blood from either infection or immunization
(6); measured on those persons ages 6-49 years.
Rubella positivity: Presence o f antibody to rubella in blood from either infection or immunization
(7); measured on those persons ages 6-49 years.
Varicella positivity: Presence o f antibody to varicella in blood from either infection or 
immunization (8) ; measured on those persons ages 6-49 years.
Toxoplasma gondii positivity : Presence o f antibody to T. gondii in blood, a marker o f past or 
current infection ( 1); measured on those persons ages 6-49 years.
Hepatitis A positivity: Presence o f antibody to HAV in blood from either infection or 
immunization (2) ; measured on those persons ages 6-49 years and over.
Cytomegalovirus positivity: Presence o f antibody to CMV in serum (3) ; measured on those ages 
6-49 years.
HSV-1 and HSV-2 positivity: Presence o f antibody to HSV-1 or HSV-2 in blood, a marker of 
current or past infection (4); measured on those ages 14-49 years.
Data source and methods
National Health and Nutrition Examination Surveys (NHANES) data were used for these 
analyses. NHANES is a cross-sectional survey designed to monitor the health and nutritional 
status o f the civilian, noninstitutionalized U.S. population ( 10) . The survey consists o f interviews 
conducted in participants’ homes, standardized physical examinations conducted in specially 
outfitted mobile examination centers, and laboratory tests utilizing blood and urine specimens 
provided by participants during the physical examination.
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The NHANES sample is selected through a complex, multistage design that includes selection 
o f primary sampling units (PSU-counties), household segments within the counties, and finally 
sample persons from selected households. The sample design includes oversampling to obtain 
reliable estimates o f health and nutritional measures for population subgroups. In 1999-2006, 
African Americans, Mexican Americans, persons with low-income, persons 12-19 years o f age, 
and persons 60 years and over were oversampled. Because o f the size and population density 
o f LAC and the large Mexican-American population, a PSU in LAC was chosen with certainty 
in each 1-year sample in NHANES. It was the only county sampled in NHANES every year.
In 1999, NHANES became a continuous survey, fielded on an ongoing basis. Public-use data 
files are released in 2-year cycles for U.S. estimates and can be grouped across cycles. Data was 
aggregated over these 6 years (1999-2004), which allowed for adequate sample size to make 
estimates for LAC ( 10).
Sample base weights were calculated to account for the differential probabilities o f selection. 
Adjustment to base weights to account for nonresponse was done separately for the LAC sample 
and the U.S. sample. Weights for the U.S. sample were post-stratified to the population control 
totals for the United States at the midpoint o f each survey cycle. Weights for the LAC sample 
were post-stratified to the midpoint o f the 1999-2004 population control totals for LAC ( 11) .
Standard errors o f the percentages were estimated using Taylor Series Linearization in SUDAAN 
version 10.0 (RTI, Research Triangle Park, N.C.), a method that incorporates the sample weights 
and sample design. Ninety-five percent confidence intervals were estimated by using the exact 
binomial method ( 12) . Differences in prevalence between the United States and LAC were 
evaluated by examining /»-values calculated using a univariate ¿-statistic obtained from the 
combined standard errors between the two samples. All differences reported are statistically 
significant (p < 0.5) unless otherwise indicated.
Because 69% o f the unweighted LAC sample was Mexican-American persons and there were 
relatively small numbers o f non-Hispanic white and non-Hispanic black persons in the LAC 
sample, race and ethnicity specific estimates were only calculated for Mexican-American persons.
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